The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
FGFR3 and Ras gene mutations are mutually exclusive genetic events in urothelial cell carcinoma
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., & Thun, M. J. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.1.5 · Cited by 3,275
Der, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas
Cappellen, D., De Oliveira, C., Ricol, D., de Medina, S., Bourdin, J., Sastre-Garau, X., Chopin, D., Thiery, J. P., & Radvanyi, F. (1999) · Nature Genetics · doi:10.1038/12615 · Cited by 713
Frequent FGFR3 Mutations in Papillary Non-Invasive Bladder (pTa) Tumors
Billerey, C., Chopin, D., Aubriot-Lorton, M.-H., Ricol, D., Gil Diez de Medina, S., Van Rhijn, B., Bralet, M.-P., Lefrere-Belda, M.-A., Lahaye, J.-B., Abbou, C. C., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64665-2 · Cited by 498
FGFR activation in skeletal disorders: Too much of a good thing
Webster, M. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(97)01131-1 · Cited by 317
Chesi, M., Brents, L. A., Ely, S. A., Bais, C., Robbiani, D. F., Mesri, E. A., Kuehl, W. M., & Bergsagel, P. L. (2001) · Blood · doi:10.1182/blood.v97.3.729 · Cited by 289
Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4
Hart, K. C., Robertson, S. C., Kanemitsu, M. Y., Meyer, A. N., Tynan, J. A., & Donoghue, D. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203650 · Cited by 276
Rigby, C. C., & Franks, L. M. (1970) · British Journal of Cancer · doi:10.1038/bjc.1970.89 · Cited by 255
van Rhijn, B. W. G., van der Kwast, T. H., Vis, A. N., Kirkels, W. J., Boevé, E. R., Jöbsis, A. C., & Zwarthoff, E. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2421 · Cited by 227
Ellis, C. A., & Clark, G. (2000) · Cellular Signalling · doi:10.1016/s0898-6568(00)00084-x · Cited by 192
Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours
Fujita, J., Yoshida, O., Yuasa, Y., Rhim, J. S., Hatanaka, M., & Aaronson, S. A. (1984) · Nature · doi:10.1038/309464a0 · Cited by 183
Bellus, G. A., Spector, E. B., Speiser, P. W., Weaver, C. A., Garber, A. T., Bryke, C. R., Israel, J., Rosengren, S. S., Webster, M. K., Donoghue, D. J., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/316892 · Cited by 174
Role of Ha-ras activation in superficial papillary pathway of urothelial tumor formation
Zhang, Z.-T., Pak, J., Huang, H.-Y., Shapiro, E., Sun, T.-T., Pellicer, A., & Wu, X.-R. (2001) · Oncogene · doi:10.1038/sj.onc.1204315 · Cited by 159
Overcoming cellular senescence in human cancer pathogenesis
Yeager, T. R., DeVries, S., Jarrard, D. F., Kao, C. H., Nakada, S. Y., Moon, T. D., Bruskewitz, R. C., Stadler, W. M., Meisner, L. F., Gilchrist, K. W., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.163 · Cited by 158
O'Toole, C., PRICE, Z. H., Ohnuki, Y., & Unsgaard, B. (1978) · British Journal of Cancer · doi:10.1038/bjc.1978.164 · Cited by 141
The genetics of transitional cell carcinoma: progress and potential clinical application
Knowles, M. A. (1999) · British Journal of Urology · doi:10.1046/j.1464-410x.1999.00217.x · Cited by 137
Self-citationHuman Bladder Carcinoma: Characterization of Two New Tumor Cell Lines and Search for Tumor Viruses23
Rasheed, S., Gardner, M. B., Rongey, R. W., Nelson‐Rees, W. A., & Arnstein, P. (1977) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/58.4.881 · Cited by 137
Theodorescu, D., Cornil, I., Fernandez, B., & Kerbel, R. S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.22.9047 · Cited by 113
Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma
Sibley, K., Heavens, D., & Knowles, M. A. (2001) · Oncogene · doi:10.1038/sj.onc.1204110 · Cited by 108
Self-citationReview Article: The Role of Ras Superfamily Proteins in Bladder Cancer Progression
OXFORD, G., & THEODORESCU, D. (2003) · Journal of Urology · doi:10.1097/01.ju.0000088670.02905.78 · Cited by 86
Improved Growth of Human Urothelial Carcinoma Cell Cultures
Grossman, H. B., Wedemeyer, G., Ren, L., et al. (1986) · The Journal of Urology · doi:10.1016/s0022-5347(17)45139-1 · Cited by 80
Reznikoff, C. A., Loretz, L. J., Christian, B. J., Wu, S.-Q., & Meisner, L. F. (1988) · Carcinogenesis · doi:10.1093/carcin/9.8.1427 · Cited by 80
A cell line from an anaplastic transitional cell carcinoma of human urinary bladder
Nayak, S. K., O'Toole, C., & PRICE, Z. H. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.21 · Cited by 78
A cell line (SCaBER) derived from squamous cell carcinoma of the human urinary bladder
O'Toole, C. M., Nayak, S. K., PRICE, Z. H., Gilbert, W. H., & Waisman, J. (1976) · International Journal of Cancer · doi:10.1002/ijc.2910170604 · Cited by 65
H-RAS, K-RAS, and N-RAS Gene Activation in Human Bladder Cancers
Przybojewska, B., Jagiełło, A., & Jałmużna, P. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(00)00223-5 · Cited by 57
Frequency of H‐ ras mutations in human bladder cancer detected by direct sequencing
Burchill, S. A., Neal, D. E., & Lunec, J. (1994) · British Journal of Urology · doi:10.1111/j.1464-410x.1994.tb07636.x · Cited by 50
Grimmond, S. M., Raghavan, D., & Russell, P. J. (1992) · Urological Research · doi:10.1007/bf00296523 · Cited by 17
Cited by
Fibroblast growth factor signalling: from development to cancer
Turner, N., & Grose, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2780 · Cited by 2,693
Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity
Knowles, M. A., & Hurst, C. D. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3817 · Cited by 1,247
Self-citationSanli, O., Dobruch, J., Knowles, M. A., Burger, M., Alemozaffar, M., Nielsen, M. E., & Lotan, Y. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.22 · Cited by 814
Self-citationFrequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder
Gui, Y., Guo, G., Huang, Y., Hu, X., Tang, A., Gao, S., Wu, R., Chen, C., Li, X., Zhou, L., et al. (2011) · Nature Genetics · doi:10.1038/ng.907 · Cited by 747
Fibroblast growth factors and their receptors in cancer
Wesche, J., Haglund, K., & Haugsten, E. M. (2011) · Biochemical Journal · doi:10.1042/bj20101603 · Cited by 534
Metadata
- Authors
- Jebar, A. H., Hurst, C. D., Tomlinson, D. C., Johnston, C., Taylor, C. F., & Knowles, M. A.
- Venue
- Oncogene
- Published
- 2005-05-09
- Volume
- 24
- Issue
- 33
- Pages
- 5218-5225
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2002714006
- Cited by
- 340
- References
- 27
- FWCI
- 13.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.